HOUSTON and HAIFA, Israel, May 25, 2023 – Nutex Health Inc. (“Nutex Health”) (NASDAQ: NUTX), a distinguished physician-led, technology-enabled integrated healthcare delivery system, and MeMed, a pioneer in the burgeoning field of advanced host response technologies, announce today a strategic partnership that expands access to the trailblazing MeMed BV test. The test distinguishes viral from bacterial infections in 15 minutes and applies machine learning to translate the complex signaling of the immune system into simple, actionable diagnostic insights. MeMed’s technology helps physicians enhance patient management and make better informed antibiotic treatment decisions.

Read more here.